Piper Jaffray Reiterates Overweight on Cerner (CERN) Ahead of MHS GENESIS Roll-Out

August 29, 2016 6:59 AM EDT
Get Alerts CERN Hot Sheet
Price: $52.54 --0%

Rating Summary:
    22 Buy, 12 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 44
Trade CERN Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Piper Jaffray reiterated an Overweight rating and $81.00 price target on Cerner (NASDAQ: CERN) as the company prepares for the roll-out of its Department of Defense contract, "MHS GENESIS." Naval Hospital Bremerton conducted system validation sessions on the “MHS GENESIS” project in preparation for the anticipated go-live on December 6, 2016. End-user training is to begin in midSeptember, and two integration validation sessions are to be conducted in October and November. Piper Jaffray believes that there is likely to be additional no-bid bookings opportunities related to the DoD contract.

Analyst Sean Wieland commented, "Cerner's roll-out of the Department of Defense contract "MHS GENESIS," remains on schedule with system validation sessions complete and go-live scheduled by year-end. We believe the impact this contract will have on numbers is being largely overlooked by investors. We have confidence in our street-high bookings growth estimates because we believe DoD bookings will accelerate in 2H17 and 2018, and tangential opportunities related to the DoD will emerge. Reiterate Overweight, $81 price target."

For an analyst ratings summary and ratings history on Cerner click here. For more ratings news on Cerner click here.

Shares of Cerner closed at $64.64 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments

Related Entities

Piper Jaffray, Sean Wieland

Add Your Comment